INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1097562996-pill-tablet-capsule-OSD-oral-solid]( "Patient-Centric Formulations In Pediatric Adherence")
Patient-Centric Formulations In Pediatric AdherenceImproving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
![molecule model-GettyImages-692883406]( "Modifying The Micro-Environment To Improve Dissolution Rate")
Modifying The Micro-Environment To Improve Dissolution RateDiscover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.
-
![GettyImages-1602744313 assay]( "Fast And Efficient Processing Of ELISA Assays")
Fast And Efficient Processing Of ELISA AssaysExplore how a streamlined ELISA workflow using automated washing and reading tools enabled accurate detection of hepatitis B markers with no false results.
-
![GettyImages-1302254900_nasal anatomy]( "White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges")
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And ChallengesExplore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
Risk Management Processes For Cell And Gene Therapies7/9/2024
Delve into several considerations of risk and knowledge management in the cell and gene therapy environment, providing essential insights for effective product development.
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
Studying The Spatial Architecture Of Glioblastoma3/24/2025
Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).
-
Easy Automation For Cell-Based Assays10/10/2025
Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
DRUG DEVELOPMENT SOLUTIONS
-
![ExionLC™ 2.0 and ExionLC™]( "ExionLC™ 2.0 and ExionLC™ 2.0+ Systems")
Reproducibility, reliability and carryover performance that meets your workflow demands, injection to injection, batch after batch.
ExionLC 2.0 and ExionLC 2.0+ systems provide full integration, control and compatibility with SCIEX mass spectrometers bringing together the speed and precision you expect for a complete solution that meets every challenge your lab faces.
-
![leica-microsystems-stellaris-8-falcon-hero]( "Lifetime Imaging In An Instant With A FLIM Microscope")
STELLARIS 8 FALCON FLIM Microscope
The contrast is clear. Lifetime imaging in an instant.
STELLARIS 8 FALCON (FAst Lifetime CONtrast) is the future of functional imaging. Harness the power of fluorescence lifetime to investigate cellular physiology and explore dynamics in living cells. STELLARIS 8 FALCON is a fully integrated solution for Fluorescence Lifetime Imaging (FLIM) and enables video-rate lifetime imaging acquisition for rapid kinetic studies in live cells.
STELLARIS 8 FALCON adds a new dimension of contrast to your imaging, opening the door to biosensing and tracking of interactions between proteins. FLIM information is now available for all modalities of the STELLARIS 8 system.
-
![Antibody antibodies GettyImages-1356994686]( "Antibody Therapeutics Purification")
We have developed an innovative portfolio of affinity chromatography resins to help you solve challenges in the downstream process of next-generation antibody therapeutics. These resins are specifically designed for the purification of engineered monoclonal antibody (mAbs) modalities.
-
![RS-DSC]( "Microcalorimetry: RS-DSC, DSC & ITC")
By harnessing cutting-edge microcalorimetry technology, researchers can unravel the complexities of molecular interactions, paving the way for groundbreaking discoveries in drug development.
-
![Pharma bioprocess quality GettyImages-1138461306]( "How Product Quality Translates To Better Results")
We care about quality because you care about your data. Every day you produce data which enables decisions that are consequential to human health, food quality, and the environment.
